John Ryan

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

Michael E. Nassif, Sheryl L. Windsor, Barry A. Borlaug et al. · Nature Medicine · 2021 · 572 citations · Full text

Hypertension, Heart Failure, Cardiomyopathy +14

Dynamin-Related Protein 1–Mediated Mitochondrial Mitotic Fission Permits Hyperproliferation of Vascular Smooth Muscle Cells and Offers a Novel Therapeutic Target in Pulmonary Hypertension

Glenn Marsboom, Péter T. Tóth, John Ryan et al. · Circulation Research · 2012 · 445 citations · Full text

Drp1 Inhibition, Pulmonary Hypertension, Novel Therapeutic Target +19

Macrophage functional polarization (M1/M2) in response to varying fiber and pore dimensions of electrospun scaffolds

Koyal Garg, Carole A. Oskeritzian, John Ryan et al. · Biomaterials · 2013 · 439 citations · Full text

Tissue Engineering, Nanofiber, Electroactive Material +12

Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades.

Donald Zimmerman, Ian Hay, Ian Gough et al. · PubMed · 1988 · 328 citations

Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

Amil M. Shah, Maja Čikeš, Narayana Prasad et al. · Journal of the American College of Cardiology · 2019 · 237 citations · Full text

Heart Failure, Echocardiographic Features, Cardiovascular Disease +8